Yuyu Atorvastatin Calcium Trihydrate Tablet 10 mg
Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Yuyu Pharmaceutical Co., Ltd.
MFDS item code 201906316 · Approved 2019.09.05
This product's status changed to Expired on 2024.09.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication helps reduce the risk of various cardiovascular diseases. It decreases the risk of myocardial infarction and stroke, and lowers the likelihood of vascular surgical procedures or angina occurrence. It is particularly effective for adults with multiple risk factors such as hypertension, smoking, and hyperlipidemia, as well as for patients with type 2 diabetes. It is also used to lower cholesterol and triglyceride levels in patients with primary hyperlipidemia and dyslipidemia. This medication helps manage cholesterol levels in young patients who have risk factors for cardiovascular diseases. Overall, it is used to reduce the risk of cardiovascular diseases and treat hyperlipidemia.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg is for patients requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol is recommended for use when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the usual adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). The dose may be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle-related adverse effects; therefore, if severe muscle pain or weakness is experienced, it should be discontinued immediately, and a physician should be consulted. Especially, if there is a significant increase in muscle-related enzyme levels or suspected severe muscle damage, the use of this medication should be stopped. Patients with liver function problems or active liver disease should not take this medication and should undergo regular liver function tests. Pregnant women, women who may become pregnant, or breastfeeding women should not take this medication and should use appropriate contraception while taking it. Children under 10 years of age and certain genetically predisposed lactose intolerant patients should also avoid this medication. Patients with a history of alcoholism or liver disease should use this medication cautiously, and elderly patients are at increased risk for myopathy and require attention. This medication may interact with several other medications; therefore, patients taking other medications should inform their physician or pharmacist. Caution is particularly needed when co-administering with certain antibiotics, antifungals, antivirals, some antihypertensives, and oral contraceptives. There is no specific antidote for overdose; treatment should be based on symptoms, and monitoring of liver function and muscle enzyme levels should be done. Keep out of reach of children and store in the original container to prevent degradation or misuse. Should symptoms such as skin rash, hives, or severe allergic reactions occur during the use of this medication, it should be discontinued immediately, and medical personnel should be informed. Additionally, patients at risk for diabetes should regularly check their blood sugar levels and consult medical personnel if abnormal symptoms arise.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to prevent exposure to air or moisture, and keep it at a temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the medication's effectiveness and prevent deterioration.
White oval film-coated tablet
100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Yuyu Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.